or Try an Advanced Search...

    Technical Analysis for SERA - Sera Prognostics, Inc

    Grade Last Price % Change Price Change
    C 9.30 -1.90% -0.18
    SERA closed down 1.9 percent on Wednesday, May 8, 2024, on 52 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical SERA trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Oversold Weakness 0.00%
    Earnings Movers Other 0.00%
    Inside Day Range Contraction 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 50 DMA Bearish -1.90%
    New Downtrend Bearish -1.90%
    Multiple of Ten Bearish Other -1.90%
    Lower Bollinger Band Touch Weakness -1.90%
    Fell Below 20 DMA Bearish -6.25%
    Older End-of-Day Signals for SERA ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 16 hours ago
    Possible NR7 about 16 hours ago
    Possible Inside Day about 16 hours ago
    Down 2 % about 20 hours ago
    Down 1% about 20 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SERA Chart by TradingView
    Basic chart:

    Profile

    Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Fertility Obstetrics Childbirth Women's Health Human Pregnancy Midwifery Pregnancy Preterm Birth

    Is SERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Sera Prognostics GAAP EPS of -$0.25 beats by $0.02
    May 8 SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
    May 7 Sera Prognostics Q1 2024 Earnings Preview
    Apr 29 Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024
    Mar 29 Chief Scientific Officer John Boniface Sells 77,136 Shares of Sera Prognostics Inc (SERA)
    Mar 27 Chief Scientific Officer John Boniface Sells 22,163 Shares of Sera Prognostics Inc (SERA)
    Mar 27 Chief Scientific Officer John Boniface Sells 21,438 Shares of Sera Prognostics Inc (SERA)
    Mar 25 Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know
    Mar 24 Sera Prognostics' PreTRM: A Speculative Buy In Women's Health
    Mar 21 Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2023 Earnings Call Transcript
    See more SERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.355
    52 Week Low 1.52
    Average Volume 182,128
    200-Day Moving Average 5.24
    50-Day Moving Average 9.66
    20-Day Moving Average 10.21
    10-Day Moving Average 10.45
    Average True Range 0.77
    RSI (14) 43.18
    ADX 33.15
    +DI 18.89
    -DI 22.51
    Chandelier Exit (Long, 3 ATRs) 10.06
    Chandelier Exit (Short, 3 ATRs) 11.32
    Upper Bollinger Bands 11.48
    Lower Bollinger Band 8.95
    Percent B (%b) 0.14
    BandWidth 24.76
    MACD Line 0.12
    MACD Signal Line 0.28
    MACD Histogram -0.1567
    Fundamentals Value
    Market Cap 282.43 Million
    Num Shares 30.4 Million
    EPS -1.23
    Price-to-Earnings (P/E) Ratio -7.56
    Price-to-Sales 806.20
    Price-to-Book 3.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.91
    Resistance 3 (R3) 9.93 9.73 9.81
    Resistance 2 (R2) 9.73 9.58 9.73 9.78
    Resistance 1 (R1) 9.52 9.48 9.42 9.50 9.74
    Pivot Point 9.32 9.32 9.27 9.32 9.32
    Support 1 (S1) 9.11 9.17 9.01 9.10 8.86
    Support 2 (S2) 8.91 9.07 8.91 8.82
    Support 3 (S3) 8.70 8.91 8.79
    Support 4 (S4) 8.69